Publication of transparency notifications PRESS RELEASE Publication of transparency notifications Liège (Belgium), 6 July 2020, 18h30 (CEST) – regulated information – In accordance with article 14 of the Act of 2 May...

Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the Offered Shares involves substantial risks and uncertainties....

Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the offered shares involves substantial risks and uncertainties....

Hyloris appoints Patrick Jeanmart as Chief Financial Officer Hyloris Pharmaceuticals SA (“Hyloris” or the “Company”) Hyloris appoints Patrick Jeanmart as Chief Financial Officer Liège, Belgium – 26 May 2020: Hyloris Pharmaceuticals SA, an innovative...